Currently, the only potential curative therapy is surgical resection of early stage lung cancer. Therefore, early detection of lung cancer could potentially increase the chance of cure by surgery and underlines the importance of screening and detection of lung cancer. In the past fifty years, ...
If the accuracy of this biomarker can be confirmed in a larger trial, this could lead to the development of a simple blood test that could be used for annual screening. The authors of the study believe that this blood test would be easier to use, more accurate and less invasive than low...
Currently, improved biomarkers are needed to differentiate lung nodules identified by new US national screening recommendations into non-cancer, cancer with poor survival probability and cancer with higher survival probability subtypes, to provide thousands of individuals with precise treatment decisions. Abst...
Early diagnosis has been proved to improve survival rate of lung cancer patients. The availability of blood-based screening could increase early lung cancer patient uptake. Our present study attempted to discover Chinese patients’ plasma metabolites as diagnostic biomarkers for lung cancer. In this wo...
Impact of Lung Cancer Screening Results on Smoking Cessation. Background Lung cancer screening programs may provide opportunities to reduce smoking rates among participants. This study evaluates the impact of lung can... Tammemägi,Martin,C.,... - 《Jnci Journal of the National Cancer Institute》...
Currently, improved biomarkers are needed to differentiate lung nodules identified by new US national screening recommendations into non-cancer, cancer with poor survival probability and cancer with higher survival probability subtypes, to provide thousands of individuals with precise treatment decisions.Abstra...
screening protocol between the activation of the study in June 2014 and December 31, 2020. They compared Lung-MAP participant characteristics to those from a set of 2,215 patients enrolled to other, individual clinical trials in advanced NSCLC that were conducted by the SWOG Cancer Research ...
Lung cancer is the leading cause of mortalities among all types of cancer. Therefore, the screening of biomarkers that are related with the progression of lung cancer is crucial for early diagnosis and efficient therapy of lung cancer. In the present study, bioinformatic analysis identified replicati...
Ideally, whole-exome sequencing would be better, but given the time constraints in the neoadjuvant setting, we need a quick turnaround because we want to reduce the time from study screening, to enrollment, to giving the drug, to resection. We want a fast turnaround with th...
In a recent article published in Lancet Oncology, Redman1demonstrated us The Lung Cancer Master Protocol (Lung-MAP;S1400) in a detailed manner. The authors introduced us screeningregistrations, assignments, and sub-study registrations ca... C Zhang,H Wang - 《Signal Transduction & Targeted Therap...